{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:29:19Z","timestamp":1792661359817,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mosquito borne viral diseases are an emerging threat as evident from the recent outbreak of Zika virus (ZIKV) as well as repeated outbreaks of Chikungunya (CHIKV), Yellow fever (YFV) and Japanese encephalitis (JEV) virus in different geographical regions. These four arboviruses are endemic in overlapping regions due to the co-prevalence of the transmitting mosquito vector species <jats:italic>Aedes<\/jats:italic> and <jats:italic>Culex<\/jats:italic>. Thus, a multivalent vaccine that targets all four viruses would be of benefit to regions of the world where these diseases are endemic. We developed a potential Virus Like Particle (VLP) based multivalent vaccine candidate to target these diseases by using stable cell lines that continuously secrete VLPs in the culture supernatants. Moreover, inclusion of Capsid in the VLPs provides an additional viral protein leading to an enhanced immune response as evident from our previous studies with ZIKV. Immunization of Balb\/c mice with different combinations of Capsid protein containing VLPs either as monovalent, bivalent or tetravalent formulation resulted in generation of high levels of neutralizing antibodies. Interestingly, the potential tetravalent VLP vaccine candidate provided strong neutralizing antibody titers against all four viruses. The 293\u2009T stable cell lines secreting VLPs were adapted to grow in suspension cultures to facilitate vaccine scale up. Our stable cell lines secreting individual VLPs provide a flexible yet scalable platform conveniently adaptable to different geographical regions as per the need. Further studies in appropriate animal models will be needed to define the efficacy of the multivalent vaccine candidate to protect against lethal virus challenge.<\/jats:p>","DOI":"10.1038\/s41598-020-61103-1","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T11:02:30Z","timestamp":1583319750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus"],"prefix":"10.1038","volume":"10","author":[{"given":"Himanshu","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Mehmetoglu-Gurbuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"61103_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.tim.2013.03.003","volume":"21","author":"SC Weaver","year":"2013","unstructured":"Weaver, S. C. Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention. Trends in microbiology 21, 360\u2013363, https:\/\/doi.org\/10.1016\/j.tim.2013.03.003 (2013).","journal-title":"Trends in microbiology"},{"key":"61103_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","volume":"85","author":"SC Weaver","year":"2010","unstructured":"Weaver, S. C. & Reisen, W. K. Present and future arboviral threats. Antiviral research 85, 328\u2013345, https:\/\/doi.org\/10.1016\/j.antiviral.2009.10.008 (2010).","journal-title":"Antiviral research"},{"key":"61103_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0188-4409(02)00378-8","volume":"33","author":"DJ Gubler","year":"2002","unstructured":"Gubler, D. J. The global emergence\/resurgence of arboviral diseases as public health problems. Archives of medical research 33, 330\u2013342 (2002).","journal-title":"Archives of medical research"},{"key":"61103_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-10-8727-1_1","volume":"1062","author":"PR Young","year":"2018","unstructured":"Young, P. R. Arboviruses: A Family on the Move. Adv Exp Med Biol 1062, 1\u201310, https:\/\/doi.org\/10.1007\/978-981-10-8727-1_1 (2018).","journal-title":"Adv Exp Med Biol"},{"key":"61103_CR5","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1128\/JVI.00252-16","volume":"90","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. & Diamond, M. S. Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere. Journal of virology 90, 4864\u20134875, https:\/\/doi.org\/10.1128\/JVI.00252-16 (2016).","journal-title":"Journal of virology"},{"key":"61103_CR6","doi-asserted-by":"publisher","first-page":"S441","DOI":"10.1093\/infdis\/jiw390","volume":"214","author":"S Yactayo","year":"2016","unstructured":"Yactayo, S., Staples, J. E., Millot, V., Cibrelus, L. & Ramon-Pardo, P. Epidemiology of Chikungunya in the Americas. The Journal of infectious diseases 214, S441\u2013S445, https:\/\/doi.org\/10.1093\/infdis\/jiw390 (2016).","journal-title":"The Journal of infectious diseases"},{"key":"61103_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s13311-016-0443-5","volume":"13","author":"H Salimi","year":"2016","unstructured":"Salimi, H., Cain, M. D. & Klein, R. S. Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis. Neurotherapeutics 13, 514\u2013534, https:\/\/doi.org\/10.1007\/s13311-016-0443-5 (2016).","journal-title":"Neurotherapeutics"},{"key":"61103_CR8","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1099\/vir.0.031641-0","volume":"92","author":"KL Mansfield","year":"2011","unstructured":"Mansfield, K. L. et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol 92, 2821\u20132829, https:\/\/doi.org\/10.1099\/vir.0.031641-0 (2011).","journal-title":"J Gen Virol"},{"key":"61103_CR9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1586\/14760584.2015.1083430","volume":"14","author":"AS Beck","year":"2015","unstructured":"Beck, A. S. & Barrett, A. D. Current status and future prospects of yellow fever vaccines. Expert Rev Vaccines 14, 1479\u20131492, https:\/\/doi.org\/10.1586\/14760584.2015.1083430 (2015).","journal-title":"Expert Rev Vaccines"},{"key":"61103_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4161\/hv.26902","volume":"10","author":"SI Yun","year":"2014","unstructured":"Yun, S. I. & Lee, Y. M. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother 10, 263\u2013279, https:\/\/doi.org\/10.4161\/hv.26902 (2014).","journal-title":"Hum Vaccin Immunother"},{"key":"61103_CR11","doi-asserted-by":"publisher","first-page":"e1002181","DOI":"10.1371\/journal.pmed.1002181","volume":"13","author":"S Flasche","year":"2016","unstructured":"Flasche, S. et al. The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study. PLoS Med 13, e1002181, https:\/\/doi.org\/10.1371\/journal.pmed.1002181 (2016).","journal-title":"PLoS Med"},{"key":"61103_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1586\/erv.12.151","volume":"12","author":"JW Wang","year":"2013","unstructured":"Wang, J. W. & Roden, R. B. Virus-like particles for the prevention of human papillomavirus-associated malignancies. Expert Rev Vaccines 12, 129\u2013141, https:\/\/doi.org\/10.1586\/erv.12.151 (2013).","journal-title":"Expert Rev Vaccines"},{"key":"61103_CR13","doi-asserted-by":"publisher","unstructured":"Garg, H., Sedano, M., Plata, G., Punke, E. B. & Joshi, A. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus. Journal of virology 91, https:\/\/doi.org\/10.1128\/JVI.00834-17 (2017).","DOI":"10.1128\/JVI.00834-17"},{"issue":"48","key":"61103_CR14","doi-asserted-by":"publisher","first-page":"7123","DOI":"10.1016\/j.vaccine.2019.09.093","volume":"37","author":"Himanshu Garg","year":"2019","unstructured":"Garg, H., Mehmetoglu-Gurbuz, T., Ruddy, G. M. & Joshi, A. Capsid containing virus like particle vaccine against Zika virus made from a stable cell line. Vaccine, https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.093 (2019).","journal-title":"Vaccine"},{"issue":"4","key":"61103_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/vaccines7040123","volume":"7","author":"Wong","year":"2019","unstructured":"Wong, S. H. et al. Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family. Vaccines (Basel) 7, https:\/\/doi.org\/10.3390\/vaccines7040123 (2019).","journal-title":"Vaccines"},{"key":"61103_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cmi.2015.05.001","volume":"21","author":"S Pils","year":"2015","unstructured":"Pils, S. & Joura, E. A. From the monovalent to the nine-valent HPV vaccine. Clin Microbiol Infect 21, 827\u2013833, https:\/\/doi.org\/10.1016\/j.cmi.2015.05.001 (2015).","journal-title":"Clin Microbiol Infect"},{"key":"61103_CR17","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1128\/JVI.69.4.1995-2003.1995","volume":"69","author":"VF Yamshchikov","year":"1995","unstructured":"Yamshchikov, V. F. & Compans, R. W. Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease. Journal of virology 69, 1995\u20132003 (1995).","journal-title":"Journal of virology"},{"key":"61103_CR18","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1073\/pnas.90.13.6218","volume":"90","author":"M Lobigs","year":"1993","unstructured":"Lobigs, M. Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3. Proc Natl Acad Sci USA 90, 6218\u20136222 (1993).","journal-title":"Proc Natl Acad Sci USA"},{"key":"61103_CR19","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1128\/JVI.72.3.2141-2149.1998","volume":"72","author":"CE Stocks","year":"1998","unstructured":"Stocks, C. E. & Lobigs, M. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM. Journal of virology 72, 2141\u20132149 (1998).","journal-title":"Journal of virology"},{"key":"61103_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-4939-0348-1_6","volume":"1138","author":"S Mukherjee","year":"2014","unstructured":"Mukherjee, S., Pierson, T. C. & Dowd, K. A. Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection. Methods Mol Biol 1138, 75\u201397, https:\/\/doi.org\/10.1007\/978-1-4939-0348-1_6 (2014).","journal-title":"Methods Mol Biol"},{"key":"61103_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","volume":"346","author":"TC Pierson","year":"2006","unstructured":"Pierson, T. C. et al. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346, 53\u201365, https:\/\/doi.org\/10.1016\/j.virol.2005.10.030 (2006).","journal-title":"Virology"},{"key":"61103_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nm.2105","volume":"16","author":"W Akahata","year":"2010","unstructured":"Akahata, W. et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nature medicine 16, 334\u2013338, https:\/\/doi.org\/10.1038\/nm.2105 (2010).","journal-title":"Nature medicine"},{"key":"61103_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","volume":"34","author":"MO Mohsen","year":"2017","unstructured":"Mohsen, M. O., Zha, L., Cabral-Miranda, G. & Bachmann, M. F. Major findings and recent advances in virus-like particle (VLP)-based vaccines. Semin Immunol 34, 123\u2013132, https:\/\/doi.org\/10.1016\/j.smim.2017.08.014 (2017).","journal-title":"Semin Immunol"},{"issue":"Suppl 8","key":"61103_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1753-6561-5-S8-P126","volume":"5","author":"L Cervera","year":"2011","unstructured":"Cervera, L., Gutierrez, S., Godia, F. & Segura, M. M. Optimization of HEK 293 cell growth by addition of non-animal derived components using design of experiments. BMC proceedings 5(Suppl 8), P126, https:\/\/doi.org\/10.1186\/1753-6561-5-S8-P126 (2011).","journal-title":"BMC proceedings"},{"key":"61103_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.actatropica.2016.11.020","volume":"166","author":"SV Mayer","year":"2017","unstructured":"Mayer, S. V., Tesh, R. B. & Vasilakis, N. The emergence of arthropod-borne viral diseases: A global prospective on dengue, chikungunya and zika fevers. Acta tropica 166, 155\u2013163, https:\/\/doi.org\/10.1016\/j.actatropica.2016.11.020 (2017).","journal-title":"Acta tropica"},{"key":"61103_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev-virology-110615-035630","volume":"3","author":"WJ Tabachnick","year":"2016","unstructured":"Tabachnick, W. J. Climate Change and the Arboviruses: Lessons from the Evolution of the Dengue and Yellow Fever Viruses. Annu Rev Virol 3, 125\u2013145, https:\/\/doi.org\/10.1146\/annurev-virology-110615-035630 (2016).","journal-title":"Annu Rev Virol"},{"key":"61103_CR27","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.clinthera.2017.07.001","volume":"39","author":"MH Collins","year":"2017","unstructured":"Collins, M. H. & Metz, S. W. Progress and Works in Progress: Update on Flavivirus Vaccine Development. Clin Ther 39, 1519\u20131536, https:\/\/doi.org\/10.1016\/j.clinthera.2017.07.001 (2017).","journal-title":"Clin Ther"},{"key":"61103_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tmaid.2016.01.006","volume":"14","author":"RN Charrel","year":"2016","unstructured":"Charrel, R. N. Diagnosis of arboviral infections\u2013A quagmire of cross reactions and complexities. Travel Med Infect Dis 14, 11\u201312, https:\/\/doi.org\/10.1016\/j.tmaid.2016.01.006 (2016).","journal-title":"Travel Med Infect Dis"},{"issue":"5","key":"61103_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/v9050097","volume":"9","author":"Michael Holbrook","year":"2017","unstructured":"Holbrook, M. R. Historical Perspectives on Flavivirus Research. Viruses 9, https:\/\/doi.org\/10.3390\/v9050097 (2017).","journal-title":"Viruses"},{"key":"61103_CR30","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1016\/j.vaccine.2015.11.023","volume":"34","author":"L Coudeville","year":"2016","unstructured":"Coudeville, L., Baurin, N. & Vergu, E. Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies. Vaccine 34, 6417\u20136425, https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.023 (2016).","journal-title":"Vaccine"},{"key":"61103_CR31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","volume":"11","author":"R Noad","year":"2003","unstructured":"Noad, R. & Roy, P. Virus-like particles as immunogens. Trends in microbiology 11, 438\u2013444 (2003).","journal-title":"Trends in microbiology"},{"key":"61103_CR32","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1056\/NEJMc1504359","volume":"372","author":"E Joura","year":"2015","unstructured":"Joura, E. & Bautista, O. & Luxembourg, A. A 9-Valent HPV Vaccine in Women. N Engl J Med 372, 2568\u20132569, https:\/\/doi.org\/10.1056\/NEJMc1504359 (2015).","journal-title":"N Engl J Med"},{"key":"61103_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"EA Joura","year":"2015","unstructured":"Joura, E. A. et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 372, 711\u2013723, https:\/\/doi.org\/10.1056\/NEJMoa1405044 (2015).","journal-title":"N Engl J Med"},{"key":"61103_CR34","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/INF.0000000000000773","volume":"34","author":"T Vesikari","year":"2015","unstructured":"Vesikari, T. et al. A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil(R) in 9-15-Year-Old Girls. Pediatr Infect Dis J 34, 992\u2013998, https:\/\/doi.org\/10.1097\/INF.0000000000000773 (2015).","journal-title":"Pediatr Infect Dis J"},{"key":"61103_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-2180-13-197","volume":"13","author":"H Garg","year":"2013","unstructured":"Garg, H., Lee, R. T., Tek, N. O., Maurer-Stroh, S. & Joshi, A. Identification of conserved motifs in the West Nile virus envelope essential for particle secretion. BMC Microbiol 13, 197, https:\/\/doi.org\/10.1186\/1471-2180-13-197 (2013).","journal-title":"BMC Microbiol"},{"key":"61103_CR36","doi-asserted-by":"publisher","first-page":"15D 13 11","DOI":"10.1002\/9780471729259.mc15d03s31","volume":"31","author":"JD Brien","year":"2013","unstructured":"Brien, J. D., Lazear, H. M. & Diamond, M. S. Propagation, quantification, detection, and storage of West Nile virus. Current protocols in microbiology 31, 15D 13 11\u201315D 13 18, https:\/\/doi.org\/10.1002\/9780471729259.mc15d03s31 (2013).","journal-title":"Current protocols in microbiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61103-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61103-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61103-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:56:01Z","timestamp":1670313361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61103-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61103"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61103-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4017"}}